Core Scientific Inc vs Nuwellis Inc — how do they compare? Core Scientific Inc trades at $22.26 (market cap $7.02B), while Nuwellis Inc trades at $3.39 (market cap $1.17M). The key difference: Core Scientific Inc is far larger — about 6000× Nuwellis Inc's market cap, and Core Scientific Inc is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals.
| CORZ | NUWE | |
|---|---|---|
Market Cap | $7.02B | $1.17M |
Sector | Technology | Technology |
52-Week High | $29.16 | $558.26 |
52-Week Low | $12.65 | $2.80 |
Enterprise Value | $8.07B | -$636.97K |
Signals from Pluang's Aura AI — not financial advice
Core Scientific (CORZ) trades at $22.71, down 3.32% today, with a bearish technical signal despite strong analyst support. The company is transitioning from Bitcoin mining to AI colocation, with Q1 2026 colocation revenue surging to $77.5M and gross margins of 57%. However, the company continues to report significant losses with a net income margin of -341.68% and negative cash flow of $525.6M in 2025.
The outlook remains speculative with substantial execution risk despite analyst optimism. While the AI pivot offers growth potential, persistent losses and cash burn present significant challenges. The consensus price target of $34.17 suggests 50% upside potential, but investors must weigh the high-risk transformation against the company's current financial instability.
No Aura AI signal available yet.
Trailing returns across standard periods
Core Scientific provides digital infrastructure for Bitcoin mining and high-performance computing (HPC). It operates purpose-built data centers to support digital asset production and AI-related workloads.
Read more on CORZ →Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →